INTRODUCTION
Arsenic is a metalloid element well known for both its acute and chronic toxicity. Many of the chronic health effects were identified as a result of its medicinal use and occupational exposure (IPCS 2001) . The most obvious effects from the long-term ingestion of arsenic are skin lesions (pigmentation and keratosis). Arsenic is also classified as a carcinogen (IARC 2002) .
Arsenic-related health effects have been seen following a number of environmental exposures, including mining and smelting activities, burning of arsenic-rich coal and ingestion of drinking water containing elevated levels of arsenic.
In 1993, the World Health Organization specified a provisional drinking-water guideline value for arsenic of 10 mg l 21 (WHO 1993) ; this has been retained in the third edition of the drinking water guidelines (WHO 2004 However, not all diseases lead to premature mortality, but they may still represent a major burden of ill health. DALYs allow comparisons between widely differing outcomes.
This is an initial attempt to examine the adequacy of existing data to underpin quantification of the global burden of disease resulting from elevated arsenic in drinking water.
METHODOLOGY
Arsenic ingestion has been implicated in a number of negative health outcomes. These health outcomes have been extensively reviewed and it has been concluded that exposure to elevated levels of arsenic via drinking water is causally related to skin lesions, peripheral vascular disease and cancer of the lungs, kidney, bladder and skin (IPCS 2001) .
Exposure
Data on populations exposed to elevated levels of drinking water arsenic were accessed through a search of the literature using database searches (including Medline and Poltox), will not necessarily affect a whole country. The numbers of people estimated to be exposed in each area were split into age groups assuming the same age distribution as the country population as a whole.
Exposure -response relationship
A literature review was conducted to identify studies on arsenic-related health effects and arsenic concentration in drinking water in order to establish possible exposureresponse relationships. A similar literature search technique was used to the one outlined above.
Disease burden
The populations assumed to be exposed to drinking water 
RESULTS

Exposure
A total of 18 different countries from eight regions 2 were found to have elevated arsenic in their drinking water supplies. These are summarised in Table 1 . There were inadequate data to determine the number of people exposed to differing arsenic concentrations greater than 50 mg l 21 .
Further analysis was, therefore, based on the single country figure shown in Table 1 . Where a population at risk estimate is a range, only the highest estimate was used for the disease burden calculation.
Exposure -response relationship
As with most environmental exposures, there are few data on which to base exposure -response relationships. Table 4 .
Disease burden
It was necessary to make a number of assumptions before the disease burden could be estimated. These are outlined below. Murray (1996) and information of similar disease outcomes (Murray & Lopez 1996) . The severity of skin lesions increases with length of exposure, to the point where they affect movement. Age is used as a surrogate measure for the length of exposure and therefore severity increases with age. † Skin lesions are not reversible after onset. † Skin lesions are not fatal (while they may progress to skin cancer this is not accounted for in this estimate) and therefore the DALY calculation is based on YLD (years lived with disability) only. † Life expectancy is 80 years. Other factors reducing study comparability include differences in population susceptibility (related to dietary or genetic factors) and differences in the ratio between As 3 þ and As 5 þ to which people are exposed.
Thus, the global burden of disease estimate outlined above is based on limited exposure-response data, which may not be globally applicable. Arsenic toxicity is seen to increase with both increasing length of exposure and the greater concentration of arsenic to which people are exposed. The method outlined in this paper provides initial estimates based on likely age-related prevalence and presumed prevalence in those exposed to arsenic concentrations greater than 50 mg l 21 . At this stage, it has not been able to account for more severe, cancer-related health outcomes.
CONCLUSIONS
Elevated arsenic concentrations in drinking water result in a significant burden of disease at the global level (ranging from 1.5 to 6.7 DALYs per 1,000 population) and, most especially, regional level, with Sear D (comprising Bangladesh, India and Nepal) being particularly badly affected.
The estimate derived in this paper relies on limited exposure-response data and relatively crude exposure data and is, thus, subject to a large degree of uncertainty.
It does, however, represent an important initial attempt to quantify this problem.
The provision of guidance for assessing burden of disease due to arsenic in drinking water at national level (Fewtrell and Fuge, in preparation) 
